Aging in Heart Failure: Embracing Biology Over Chronology: JACC Family Series

Overview

Journal JACC Heart Fail

Publisher Elsevier

Date 2024 Apr 10

PMID 38597865

Authors

Parag Goyal

Mathew S Maurer

Jason Roh

Affiliations

Soon will be listed here.

Abstract

Age is among the most potent risk factors for developing heart failure and is strongly associated with adverse outcomes. As the global population continues to age and the prevalence of heart failure rises, understanding the role of aging in the development and progression of this chronic disease is essential. Although chronologic age is on a fixed course, biological aging is more variable and potentially modifiable in patients with heart failure. This review describes the current knowledge on mechanisms of biological aging that contribute to the pathogenesis of heart failure. The discussion focuses on 3 hallmarks of aging-impaired proteostasis, mitochondrial dysfunction, and deregulated nutrient sensing-that are currently being targeted in therapeutic development for older adults with heart failure. In assessing existing and emerging therapeutic strategies, the review also enumerates the importance of incorporating geriatric conditions into the management of older adults with heart failure and in ongoing clinical trials.

Citing Articles

Long-term dietary allyl isothiocyanate, a TRPA1 agonist, ameliorates cardiac fibrosis and diastolic dysfunction in aged mice.

Qian C, Fernandez Z, Sadeghi S, Fotouhi A, Sun L, Wang D Geroscience. 2025; .

PMID: 40072784 DOI: 10.1007/s11357-025-01603-y.

Global, regional, and national burden of heart failure and its underlying causes, 1990-2021: results from the global burden of disease study 2021.

Ran J, Zhou P, Wang J, Zhao X, Huang Y, Zhou Q Biomark Res. 2025; 13(1):16.

PMID: 39849627 PMC: 11755835. DOI: 10.1186/s40364-025-00728-8.

Explainable AI associates ECG aging effects with increased cardiovascular risk in a longitudinal population study.

Hempel P, Ribeiro A, Vollmer M, Bender T, Dorr M, Krefting D NPJ Digit Med. 2025; 8(1):25.

PMID: 39806125 PMC: 11730300. DOI: 10.1038/s41746-024-01428-7.

Fueling the Heart: What Are the Optimal Dietary Strategies in Heart Failure?.

Ataran A, Pompian A, Hajirezaei H, Lodhi R, Javaheri A Nutrients. 2024; 16(18).

PMID: 39339757 PMC: 11434961. DOI: 10.3390/nu16183157.

References

Selkoe D, Hardy J . The amyloid hypothesis of Alzheimer's disease at 25 years. EMBO Mol Med. 2016; 8(6):595-608. PMC: 4888851. DOI: 10.15252/emmm.201606210. View

Ruberg F, Berk J . Transthyretin (TTR) cardiac amyloidosis. Circulation. 2012; 126(10):1286-300. PMC: 3501197. DOI: 10.1161/CIRCULATIONAHA.111.078915. View

Abdellatif M, Trummer-Herbst V, Koser F, Durand S, Adao R, Vasques-Novoa F . Nicotinamide for the treatment of heart failure with preserved ejection fraction. Sci Transl Med. 2021; 13(580). PMC: 7611499. DOI: 10.1126/scitranslmed.abd7064. View

van der Pol A, van Gilst W, Voors A, van der Meer P . Treating oxidative stress in heart failure: past, present and future. Eur J Heart Fail. 2018; 21(4):425-435. PMC: 6607515. DOI: 10.1002/ejhf.1320. View

Dai D, Hsieh E, Chen T, Menendez L, Basisty N, Tsai L . Global proteomics and pathway analysis of pressure-overload-induced heart failure and its attenuation by mitochondrial-targeted peptides. Circ Heart Fail. 2013; 6(5):1067-76. PMC: 3856238. DOI: 10.1161/CIRCHEARTFAILURE.113.000406. View

Kitzman D, Brubaker P, Morgan T, Haykowsky M, Hundley G, Kraus W . Effect of Caloric Restriction or Aerobic Exercise Training on Peak Oxygen Consumption and Quality of Life in Obese Older Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial. JAMA. 2016; 315(1):36-46. PMC: 4787295. DOI: 10.1001/jama.2015.17346. View

Roshanravan B, Liu S, Ali A, Shankland E, Goss C, Amory J . In vivo mitochondrial ATP production is improved in older adult skeletal muscle after a single dose of elamipretide in a randomized trial. PLoS One. 2021; 16(7):e0253849. PMC: 8282018. DOI: 10.1371/journal.pone.0253849. View

Tian Y, Cropley V, Maier A, Lautenschlager N, Breakspear M, Zalesky A . Heterogeneous aging across multiple organ systems and prediction of chronic disease and mortality. Nat Med. 2023; 29(5):1221-1231. DOI: 10.1038/s41591-023-02296-6. View

Xie S, Xu S, Deng W, Tang Q . Metabolic landscape in cardiac aging: insights into molecular biology and therapeutic implications. Signal Transduct Target Ther. 2023; 8(1):114. PMC: 10015017. DOI: 10.1038/s41392-023-01378-8. View

10.

Arany Z, He H, Lin J, Hoyer K, Handschin C, Toka O . Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle. Cell Metab. 2005; 1(4):259-71. DOI: 10.1016/j.cmet.2005.03.002. View

11.

Harman D . Aging: a theory based on free radical and radiation chemistry. J Gerontol. 1956; 11(3):298-300. DOI: 10.1093/geronj/11.3.298. View

12.

Taneike M, Yamaguchi O, Nakai A, Hikoso S, Takeda T, Mizote I . Inhibition of autophagy in the heart induces age-related cardiomyopathy. Autophagy. 2010; 6(5):600-6. DOI: 10.4161/auto.6.5.11947. View

13.

Cherubini A, Oristrell J, Pla X, Ruggiero C, Ferretti R, Diestre G . The persistent exclusion of older patients from ongoing clinical trials regarding heart failure. Arch Intern Med. 2011; 171(6):550-6. DOI: 10.1001/archinternmed.2011.31. View

14.

Liu X, Xiao J, Zhu H, Wei X, Platt C, Damilano F . miR-222 is necessary for exercise-induced cardiac growth and protects against pathological cardiac remodeling. Cell Metab. 2015; 21(4):584-95. PMC: 4393846. DOI: 10.1016/j.cmet.2015.02.014. View

15.

Blackwood E, Azizi K, Thuerauf D, Paxman R, Plate L, Kelly J . Pharmacologic ATF6 activation confers global protection in widespread disease models by reprograming cellular proteostasis. Nat Commun. 2019; 10(1):187. PMC: 6331617. DOI: 10.1038/s41467-018-08129-2. View

16.

LEHMAN J, Barger P, Kovacs A, Saffitz J, Medeiros D, Kelly D . Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J Clin Invest. 2000; 106(7):847-56. PMC: 517815. DOI: 10.1172/JCI10268. View

17.

Block R, Liu L, Herrington D, Huang S, Tsai M, OConnell T . Predicting Risk for Incident Heart Failure With Omega-3 Fatty Acids: From MESA. JACC Heart Fail. 2019; 7(8):651-661. DOI: 10.1016/j.jchf.2019.03.008. View

18.

Schaum N, Lehallier B, Hahn O, Palovics R, Hosseinzadeh S, Lee S . Ageing hallmarks exhibit organ-specific temporal signatures. Nature. 2020; 583(7817):596-602. PMC: 7757734. DOI: 10.1038/s41586-020-2499-y. View

19.

Tchkonia T, Palmer A, Kirkland J . New Horizons: Novel Approaches to Enhance Healthspan Through Targeting Cellular Senescence and Related Aging Mechanisms. J Clin Endocrinol Metab. 2020; 106(3):e1481-e1487. PMC: 7947756. DOI: 10.1210/clinem/dgaa728. View

20.

Cooper L, Lu D, Mentz R, Rogers J, Milano C, Felker G . Cardiac transplantation for older patients: Characteristics and outcomes in the septuagenarian population. J Heart Lung Transplant. 2015; 35(3):362-369. PMC: 4789155. DOI: 10.1016/j.healun.2015.10.028. View